Meridia Risk Management Program Sufficiently Addresses Safety Issues, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency denies Public Citizen petition to remove Abbott’s weight loss drug Meridia (sibutramine) from the market.